4
Changes in Ownership
Acrivon Therapeutics, Inc. Filed Acc 0000905148-24-002277
President and CEO gave up 59,765 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Blume-Jensen Peter · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-14 | Shares withheld for taxes : show line 1 in the form | −59,765 | $7.02 | $419,550 | 2,502,129 | D |
Loading xslF345X05/form4.xml…